Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHR8554 injection for postoperative analgesia after abdominal surgery
CTR20210284Phase 3Completed
- Sponsor
- Hengrui Therapeutics
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tegileridine in postoperative pain, sponsored by Hengrui Therapeutics. Started Feb 2021; status: completed.
02
Drugs
tegileridine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20210284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210284.